Abstract:Congenital myasthenia syndromes (CMS) are caused by genetic defects that impair neuromuscular transmission. Efficient synaptic transmission at the neuromuscular junction (NMJ) incorporates many different proteins involved both in the signal transmission itself and in generating the prerequisite specialized synaptic structures. As a consequence, there are multiple pathogenic mechanisms that can underlie CMS. A recent comprehensive review of CMS highlights many of these mechanisms [1▪▪] . There are currently 35 genes reported to be associated with CMS (Fig. 1 and Table 1). The prevalence reported varies considerably between regions, 2.8–14.8 per million (UK), 1.8 per million (Brazil), and 22.2 per million (Slovenia) [2] . Differences are likely to occur because of mutation founder effects in certain regions and historically because of different pick-up rates as new detection technologies are adopted. The clinical use of next-generation sequencing greatly facilitates detection of mutations in larger genes, such as AGRN , LRP4 , MUSK , COLQ , and thus increases in reported prevalence is likely to continue [3–7] . Whilst symptom onset at birth or infancy is the commonest presentation, later onset in childhood and adult life is now increasingly recognized. The clinical phenotypes can vary in the subtypes, but the hallmark is fatigable weakness predominantly affecting axial and proximal limb muscle, ocular, bulbar and or respiratory involvement. A suspected diagnosis is based on typical clinical features, decremental responses of 10% or more on repetitive nerve stimulation (RNS) and/or abnormal jitter and block on single-fibre EMG. It is prudent to note that RNS may show incremental response on high-frequency stimulation in some presynaptic (VAMP1, UNC13A, SYT2, RPH3A) and one synaptic (LAMA5) CMS subtype [8,9] . The inheritance patten in CMS is autosomal recessive except for dominant pattern seen in slow channel syndromes, SNAP25, PURA and some SYT2 patients [1▪▪] . Here, we highlight the widening phenotype spectrum associated with gene mutations that can not only have an effect of the NMJ but also show systemic and brain involvement (Table 2), and on current and emerging therapeutic strategies for CMS.

Rare disease research workflow using multilayer networks elucidates the molecular determinants of severity in Congenital Myasthenic Syndromes

A Multimodal Approach as a Model for Rare Disorders

Multiscale networks in multiple sclerosis

Rare diseases, spotlighting amyotrophic lateral sclerosis, Huntington’s disease, and myasthenia gravis: Insights from landscape analysis of current research

Rare diseases: Insights from landscape analysis of current research, spotlighting amyotrophic lateral sclerosis, Huntington’s disease, and myasthenia gravis

A Structural Bioinformatics Investigation

The systemic complexity of a monogenic disease: the molecular network of spinal muscular atrophy

Diagnostic yield of a practical electrodiagnostic protocol discriminating between different congenital myasthenic syndromes

Fostering collaborative research for rare genetic disease: the example of niemann-pick type C disease

Teamwork makes the dream work: functional collaborations between families, scientists, and healthcare providers to drive progress in the treatment of Leigh Syndrome

A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot–Marie–Tooth neuropathy 1A

Deepening the knowledge of rare diseases dependent on angiogenesis through semantic similarity clustering and network analysis

A cell type-aware framework for nominating non-coding variants in Mendelian regulatory disorders

Clinical exome sequencing in the diagnosis of pediatric neuromuscular disease

Congenital myasthenic syndromes: increasingly complex

[Rare diseases: unraveling the biological bases to find future therapies]

Undiagnosed Disease Network collaborative approach in diagnosing rare disease in a patient with a mosaic CACNA1D variant

Visualization of automatically combined disease maps and pathway diagrams for rare diseases

Joint, multifaceted genomic analysis enables diagnosis of diverse, ultra-rare monogenic presentations

Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review

A Copernican Revolution of Multigenic Analysis: A Retrospective Study on Clinical Exome Sequencing in Unclear Genetic Disorders